Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 47
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01848457 | Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy | ||
| NCT03006848 | A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma | ||
| NCT05721248 | STOP-HER2: Stopping Trastuzumab in HER2+ MBC | ||
| NCT02482376 | Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer | ||
| NCT02109627 | Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML | ||
| NCT02553460 | Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | ||
| NCT03657576 | Trial of C134 in Patients With Recurrent GBM | ||
| NCT01201694 | Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) | ||
| NCT04898894 | Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | ||
| NCT02530125 | Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission | ||
| NCT00578396 | Phase I Biomarker Study of Dietary Grape-derived Low Dose Resveratrol for Colon Cancer Prevention | ||
| NCT04716725 | 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer | ||
| NCT03808558 | Phase 2 Study of TVB-2640 in KRAS Non-Small Cell Lung Carcinomas | ||
| NCT03587740 | ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer | ||
| NCT02482389 | Study of Preoperative Boost Radiotherapy | ||
| NCT01823991 | COGNUTRIN in Breast Cancer Survivors | ||
| NCT04416568 | Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers | ||
| NCT05029999 | CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer | ||
| NCT04483206 | Personalized Autologous Transplant for Multiple Myeloma | ||
| NCT02435550 | iCare for Cancer Patients | ||
| NCT05318469 | Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer | ||
| NCT06200155 | Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy | ||
| NCT02344355 | A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | ||
| NCT05669846 | Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC | ||
| NCT04580446 | HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer | ||
| NCT03446638 | iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes | ||
| NCT01852890 | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I | ||
| NCT05053750 | TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer | ||
| NCT03194932 | Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Leukemia of Ambiguous Lineage | ||
| NCT05030441 | Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 | ||
| NCT02754752 | Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment | ||
| NCT05458284 | The Effect of Acupuncture on Nerve Pain Caused by Taxane (Chemotherapy) Treatment | ||
| NCT04397003 | Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer | ||
| NCT01861002 | A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML | ||
| NCT05292664 | Venetoclax Basket Trial for High Risk Hematologic Malignancies | ||
| NCT01591356 | EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors | ||
| NCT03093909 | Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases | ||
| NCT01713400 | Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease | ||
| NCT00668707 | Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality | ||
| NCT06030037 | Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma | ||
| NCT04883671 | Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: the SOLAR Trial | ||
| NCT06268015 | Botensilimab and Balstilimab Optimization in Colorectal Cancer | ||
| NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | ||
| NCT05101551 | Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy | ||
| NCT00519545 | Prayer as a Possible Adjuvant Treatment for Breast Cancer | ||
| NCT06263153 | Futibatinib in Combination with Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy | ||
| NCT01067287 | Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation |
